Related Experiment Video
Updated: Apr 27, 2026

Cell Membrane Repair Assay Using a Two-photon Laser Microscope
Published on: January 2, 2018
Dysferlin regulates cell membrane repair by facilitating injury-triggered acid sphingomyelinase secretion
A Defour1, J H Van der Meulen1, R Bhat1
1Center for Genetic Medicine Research, Children's National Medical Center, 111 Michigan Avenue NW, Washington, DC, USA.
Abstract:
Dysferlin deficiency compromises the repair of injured muscle, but the underlying cellular mechanism remains elusive. To study this phenomenon, we have developed mouse and human myoblast models for dysferlinopathy. These dysferlinopathic myoblasts undergo normal differentiation but have a deficit in their ability to repair focal injury to their cell membrane. Imaging cells undergoing repair showed that dysferlin-deficit decreased the number of lysosomes present at the cell membrane, resulting in a delay and reduction in injury-triggered lysosomal exocytosis. We find repair of injured cells does not involve formation of intracellular membrane patch through lysosome-lysosome fusion; instead, individual lysosomes fuse with the injured cell membrane, releasing acid sphingomyelinase (ASM). ASM secretion was reduced in injured dysferlinopathic cells, and acute treatment with sphingomyelinase restored the repair ability of dysferlinopathic myoblasts and myofibers. Our results provide the mechanism for dysferlin-mediated repair of skeletal muscle sarcolemma and identify ASM as a potential therapy for dysferlinopathy.
Insights
Dysferlin deficiency impairs muscle membrane repair by reducing lysosomal exocytosis. Restoring acid sphingomyelinase (ASM) activity can rescue this defect, offering a potential therapy for dysferlinopathy.
Area of Science:
- Muscle biology
- Cellular repair mechanisms
- Lysosomal function
Background:
- Dysferlin deficiency impairs skeletal muscle membrane repair, but the cellular mechanisms are not fully understood.
- Dysferlinopathy affects muscle regeneration and function, highlighting the need to elucidate its molecular basis.
Purpose of the Study:
- To investigate the cellular mechanism of impaired muscle membrane repair in dysferlinopathy.
- To identify potential therapeutic targets for dysferlinopathy.
Main Methods:
- Developed mouse and human myoblast models of dysferlinopathy.
- Utilized live-cell imaging to observe membrane repair processes.
- Assessed lysosomal exocytosis and acid sphingomyelinase (ASM) secretion in response to injury.
Main Results:
- Dysferlin-deficient myoblasts showed reduced lysosomal exocytosis at the cell membrane following injury.
- Individual lysosomes, not lysosome-lysosome fusion, mediate membrane repair through fusion with the sarcolemma.
- Reduced ASM secretion was observed in injured dysferlinopathic cells; exogenous ASM treatment restored repair capacity.
Conclusions:
- Dysferlin is crucial for efficient lysosomal exocytosis, a key mechanism in skeletal muscle sarcolemma repair.
- Acid sphingomyelinase (ASM) plays a vital role in this repair process.
- ASM represents a promising therapeutic target for treating dysferlinopathy.
Related Concept Videos
Enlargement of the Plasma Membrane
Assembly of the Lipid Bilayer in the ER
A large chunk of any biological membrane is composed of phospholipids. These lipids have a heterogeneous distribution across different subcellular organelles and even between...
Asymmetric Lipid Bilayer
Desmosomes
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Cell Motility through Blebbing
Blebbing Through the Matrix
In multicellular...

